Bank Of Montreal Arbutus Biopharma Corp Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Bank Of Montreal holds 354,813 shares of ABUS stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354,813

Previous 334,265 6.15%

Holding current value

$1.4 Million

Previous $862,000 27.15%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.52 - $3.63 $51,780 - $74,589	20,548 Added 6.15%	354,813 $1.1 Million
Q1 2024 May 13, 2024	SELL	$2.26 - $2.92 $40,679 - $52,560	-18,000 Reduced 5.11%	334,265 $862,000
Q4 2023 Feb 08, 2024	BUY	$1.69 - $2.54 $54,216 - $81,485	32,081 Added 10.02%	352,265 $880,000
Q3 2023 Nov 01, 2023	SELL	$1.9 - $2.27 $205,369 - $245,362	-108,089 Reduced 25.24%	320,184 $649,000
Q2 2023 Aug 02, 2023	BUY	$2.24 - $3.06 $242,995 - $331,948	108,480 Added 33.92%	428,273 $985,000
Q1 2023 Jun 13, 2024	SELL	$2.23 - $3.1 $37,486 - $52,111	-16,810 Reduced 5.03%	317,455 $961,000
Q4 2022 Feb 01, 2023	SELL	$1.91 - $2.85 $401 - $598	-210 Reduced 0.07%	319,793 $745,000
Q3 2022 Nov 10, 2022	SELL	$1.88 - $2.88 $15,902 - $24,361	-8,459 Reduced 2.58%	320,003 $707,000
Q2 2022 Aug 11, 2022	BUY	$1.98 - $3.17 $19,566 - $31,325	9,882 Added 3.1%	328,462 $869,000
Q1 2022 May 12, 2022	BUY	$2.42 - $3.98 $197,767 - $325,253	81,722 Added 34.5%	318,580 $953,000
Q4 2021 Feb 11, 2022	BUY	$3.11 - $4.61 $75,563 - $112,009	24,297 Added 11.43%	236,858 $921,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $104,622 - $182,397	-39,480 Reduced 15.66%	212,561 $910,000
Q2 2021 Aug 12, 2021	BUY	$2.5 - $3.51 $630,102 - $884,663	252,041 New	252,041 $796,000

Others Institutions Holding ABUS

# of Institutions

138

Shares Held

95.4M

Call Options Held

3.44M

Put Options Held

377K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $591M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account